Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: Insights from a patient survey

Atherosclerosis Supplements

Volumn 15, Issue 2, 2014, Pages 46-51

  Bruckert, Eric ^a   Saheb, Samir ^a   Bonté, Juliette Roth ^b   Coudray Omnès, Carole ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CEMKA EVAL   (France)

Author keywords

Burden of disease; Homozygous familial hypercholesterolaemia; Patient survey; Psychosocial factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HEALTH CARE NEED; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MALE; PERSONAL EXPERIENCE; SEMI STRUCTURED INTERVIEW; SOCIAL PSYCHOLOGY; ADOLESCENT; BLOOD; DAILY LIFE ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; FOLLOW UP; HOMOZYGOTE; MIDDLE AGED; PATIENT EDUCATION; PROCEDURES; PROGNOSIS; PSYCHOLOGY; PSYCHOMETRY; QUESTIONNAIRE; YOUNG ADULT;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PROGNOSIS; PSYCHOMETRICS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84908129423     PISSN: 15675688     EISSN: 18785050     Source Type: Journal    
DOI: 10.1016/j.atherosclerosissup.2014.07.006     Document Type: Article

References (15)

1. Gagné C., Gaudet D., Bruckert E., Ezetimibe Study G. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 2002, 105:2469-2475.
2. Graesdal A., Bogsrud M.P., Holven K.B., Nenseter M.S., Narverud I., Langslet G., et al. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia. J Clin Lipidol 2012, 6:331-339.
3. Raal F.J., Pilcher G.J., Panz V.R., van Deventer H.E., Brice B.C., Blom D.J., et al. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation 2011, 124:2202-2207.
4. Goldberg A.C., Hopkins P.N., Toth P.P., Ballantyne C.M., Rader D.J., Robinson J.G., et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011, 5:133-140.
5. Goldstein J.K., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The metabolic basis of inherited disease 2001, 2863-2913. McGraw-Hill, New York. 8th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
6. Raal F.J., Santos R.D. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Atherosclerosis 2012, 223:262-268.
7. Bruckert E. Recommendations for the management of patients with homozygous familial hypercholesterolaemia: Overview of a new European Atherosclerosis Society consensus statement. Atherosclerosis Supplements 2014, 15:26-32.
8. Thompson G.R., Barbir M., Davies D., Dobral P., Gesinde M., Livingston M., et al. Efficacy criteria and cholesterol targets for LDL apheresis. Atherosclerosis 2010, 208:317-321.
9. Health Quality Ontario Low-density lipoprotein apheresis: an evidence-based analysis. Ont Health Technol Assess Ser 2007, 7:1-101.
10. European Commission Labour force survey overview 2012. European union labour force survey - annual results 2012 2012, Available from:. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Labour_force:survey_overview_2012.
11. Muller-Nordhorn J., Englert H., Wegscheider K., Berger H., Sonntag F., Voller H., et al. Productivity loss as a major component of disease-related costs in patients with hypercholesterolemia in Germany. Clin Res Cardiol 2008, 97:152-159.
12. Azambuja M.I., Foppa M., Maranhao M.F., Achutti A.C. Economic burden of severe cardiovascular diseases in Brazil: an estimate based on secondary data. Arq Bras Cardiol 2008, 91:148-155. 163-171.
13. Holland P., Burstrom B., Moller I., Whitehead M. Socioeconomic inequalities in the employment impact of ischaemic heart disease: a longitudinal record linkage study in Sweden. Scand J Public Health 2009, 37:450-458.
14. Claessens P., Moons P., de Casterle B.D., Cannaerts N., Budts W., Gewillig M. What does it mean to live with a congenital heart disease? A qualitative study on the lived experiences of adult patients. Eur J Cardiovasc Nurs 2005, 4:3-10.
15. Kovacs A.H., Saidi A.S., Kuhl E.A., Sears S.F., Silversides C., Harrison J.L., et al. Depression and anxiety in adult congenital heart disease: predictors and prevalence. Int J Cardiol 2009, 137:158-164.